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Abstract 6 
Objective. Reducing the rate of severe postpartum haemorrhage (PPH) is a major challenge in 7 
obstetrics today. One potentially effective tool for improving the quality of care is the clinical audit, 8 
that is, peer evaluation and comparison of actual practices against explicit criteria. Our objective was 9 
to assess the impact of regular criteria-based audits on the prevalence of severe PPH. 10 
Design. Quasi-experimental before-and-after survey 11 
Setting. Two French maternity units in the Rhône-Alpes region, with different organisation of care. 12 
Participants. All staff of both units. 13 
Intervention. Quarterly clinical audit meetings at which a team of reviewers analysed all cases of 14 
severe PPH and provided feedback on quality of care and where all staff actively participated. 15 
Main outcome measures. The primary outcome was the prevalence of severe PPH. Secondary 16 
outcomes included the global quality of care for women with severe PPH, including the performance 17 
rate for each recommended procedure. Differences in these variables between 2005 and 2008 were 18 
tested. 19 
Results. The prevalence of severe PPH declined significantly in both units, from 1.52% to 0.96% of 20 
deliveries in the level III hospital (p=0.048) and from 2.08% to 0.57% in the level II hospital 21 
(p<0.001). From 2005 to 2008, the proportion of deliveries with severe PPH that were managed 22 
consistently with the guidelines increased for all of its main components, in both units. 23 
Conclusion. Regular clinical audits of cases severe PPH were associated with a persistent reduction in 24 
the prevalence of severe PPH. 25 
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Introduction 26 
Severe postpartum haemorrhage (PPH) is the main component of severe maternal morbidity in 27 
developed countries, and reducing its rate is a major challenge in obstetrics today. In France, PPH is 28 
the leading cause of maternal mortality, and data from the French Confidential Enquiries into maternal 29 
deaths show that 80% of deaths due to PPH might have been prevented by timely and appropriate care 30 
(1). The French College of Obstetrics & Gynaecology (CNGOF) issued the first national clinical 31 
guidelines on PPH prevention and management in France in November 2004 (2). However, the 32 
passive dissemination of guidelines is by itself insufficient to change professionals’ practices (3).  33 
Clinical audit is a quality improvement process that seeks to improve patient care and outcomes by 34 
looking at current actual practices through the review of cases according to explicit criteria and uses 35 
the findings to modify the organisation and the content of care if necessary (4, 5). Few studies have 36 
assessed the impact of clinical audits in obstetrics (6,7,8), and none, to our knowledge, has focused 37 
specifically on PPH. Information on the feasibility of clinical audits of deliveries with severe PPH and 38 
the results that can be expected from this tool would be useful to clinicians (9).  39 
The Pithagore6 trial was a cluster-randomised trial, with the maternity unit as the unit of 40 
randomisation, to evaluate a multifaceted educational intervention for reducing the rate of severe PPH. 41 
It included 106 French maternity units and finally found no significant difference in the severe PPH 42 
rate between the hospitals with the intervention and the control hospitals (10). The intervention 43 
included a clinical audit of deliveries with severe PPH in all maternity units in the intervention arm. 44 
Two of these hospitals decided to continue the clinical audit meetings on a regular basis. The objective 45 
of this report is to describe the change in the prevalence of severe PPH and in the quality of care 46 
provided in these cases after the implementation of routine audits in two hospitals with different levels 47 
and organisation of care. 48 
49 
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Methods  50 
A before-and-after survey was designed to assess the impact of the routine use of clinical audits. 51 
Population 52 
The study was conducted in France in two maternity hospitals located in the Rhône-Alpes region. Both 53 
were part of the Pithagore6 research program (10) and decided, after the study's conclusion, to 54 
integrate the clinical audit into their routine practice. Croix-Rousse Hospital is a level III university 55 
hospital, that is, a reference centre with an onsite neonatal intensive care unit and around 3000 56 
deliveries a year. Valence Hospital is a level II hospital that has a neonatal unit and around 2000 57 
annual deliveries. Both units have an anaesthetist and a junior and a senior obstetrician on site at all 58 
times, as well as an onsite blood bank, arterial embolisation facilities and an adult intensive care unit. 59 
They also have written protocols, consistent with national guidelines, for the management of obstetric 60 
haemorrhages. 61 
 62 
From 2005 through 2008, the obstetrics departments of both hospitals held clinical audit meetings 63 
every three months to analyse all cases of severe PPH in the preceding quarter. Severe PPH was 64 
defined as a PPH associated with one or more of the following: blood transfusion, arterial 65 
embolisation, arterial ligation, other conservative uterine surgery, hysterectomy, transfer to an 66 
intensive care unit, peripartum haemoglobin drop of 4 g/dl or more, or maternal death. Women with 67 
transfusions during the postpartum period but not clinically diagnosed with PPH were not included. 68 
Deliveries with severe PPH were prospectively identified and reported at the daily obstetric staff 69 
meeting, and one midwife in each hospital was responsible for collecting cases and checking that all 70 
pertinent information was included in the file. 71 
 72 
Clinical audit 73 
In each unit, all cases of severe PPH that occurred during the previous 3 months were reviewed during 74 
a quarterly meeting of the local clinicians. All members of maternity unit's medical staff (obstetricians, 75 
midwives and anaesthetists) were asked to participate. Participation in this meeting was considered 76 
working time. From 20 to 25 people attended each meeting. In each unit, a three-member audit team 77 
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— an obstetrician, a midwife and an anaesthetist — conducted the clinical audit. A member of the 78 
team caring for the woman at the time the PPH occurred presented each case. The content of the 79 
obstetric files was also available to the audit team.  80 
The clinical audit included three steps. First, the appropriateness of the care provided was critically 81 
analysed by the audit team in a discussion with the other clinicians. Management was assessed 82 
according to explicit criteria derived from the main components of the national guidelines: 83 
examination of the uterine cavity and/or manual removal of the placenta within 15 minutes of the PPH 84 
diagnosis; instrumental examination of the vagina and cervix; intravenous administration of oxytocin; 85 
and if PPH persisted and was due to uterine atony, intravenous administration of sulprostone (second 86 
line oxytocic) within 30 minutes of the initial diagnosis. A standardised audit form (available on 87 
request to the authors) was completed for each case and stated whether each recommended procedure 88 
was performed.  89 
At the end of this analysis, the audit team offered an oral synthesis of the practices, feedback about 90 
what was done wrong and what was done well, and a consensus was then made by the audit meeting 91 
on the global quality of care provided (optimal, suboptimal, non-optimal). Care was considered 92 
optimal if the following four major components of recommended care were performed within the 93 
required time: examination of the uterine cavity/manual removal of placenta; call for additional staff; 94 
administration of oxytocin; and administration of sulprostone if uterine atony persisted. If at least one 95 
of these major components was absent, care was considered non-optimal. Care was considered 96 
suboptimal if all major procedures were performed but at least one was not done within the 97 
recommended time or another minor component of care did not comply with the recommendations. 98 
The second step of the audit consisted in an active discussion involving all meeting participants and 99 
facilitated by the audit team to identify the specific reasons for sub- or non-optimal care, both in terms 100 
of content and organization. Finally, the group analysed the reasons identified in the second step and 101 
defined practical ways to improve the specific non-optimal aspects, in view of local constraints and the 102 
specific context. One person, usually a senior midwife, was in charge of monitoring implementation of 103 
the recommended actions. After the meeting, the senior midwife reduced these conclusions to writing 104 
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and sent them by email to each participant. They were also made available to all staff of the maternity 105 
unit in the labour ward. 106 
 107 
Study variables 108 
The data routinely collected by the units includes characteristics of pregnancy and delivery known to 109 
be risk factors for severe PPH: previous caesarean delivery, multiple pregnancy, placenta praevia or 110 
accreta, mode of delivery, and foetal macrosomia (baby’s weight > 4000 g), as well as any postpartum 111 
haemorrhage (clinically assessed by the caregivers). These data were extracted for this study, together 112 
with their proportions among annual deliveries (from each unit’s annual report).  113 
The primary outcome was the prevalence of severe PPH, calculated as the number of cases divided by 114 
the total number of deliveries. Secondary outcomes included the rates of the principal recommended 115 
interventions for PPH management, extracted from the data collected during the audits. Specifically, 116 
we calculated the rate of calls for additional staff and administration of oxytocin for all cases. The 117 
rates of examination of the uterine cavity within 15 minutes of diagnosis and of instrumental 118 
examination of the vagina and cervix were assessed for severe PPH following vaginal delivery. Lastly, 119 
the rate of administration of sulprostone within 30 minutes of the diagnosis was assessed for the cases 120 
due to uterine atony.  121 
 122 
Analysis 123 
Differences between the before (2005) and after (2008) periods for primary and secondary outcomes 124 
were tested with the chi-square test or Fisher’s exact test, as appropriate, as were differences in the 125 
prevalence of individual risk factors for severe PPH between these periods. 126 
 127 
Results  128 
The characteristics of parturient women did not change significantly from 2005 to 2008 in the level II 129 
unit, although in the level III unit, the rate of instrumental vaginal deliveries increased significantly, 130 
from 7.3% in 2005 to 10.5% in 2008, as did the rate of deliveries with PPH, from 4.0% of deliveries in 131 
2005 to 6.1% in 2008 (Table 1). This global increase in the PPH annual rate resulted from the 132 
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combination of a decrease in PPH after spontaneous and instrumental vaginal deliveries (from 2.0% to 133 
1.85% and from 7.9% to 3.5%, respectively) and a concomitant significant increase in the PPH rate 134 
after caesarean deliveries, from 9.6% in 2005 to 20.4% in 2008. 135 
A significant reduction in the prevalence of severe PPH occurred in both hospitals between 2005 and 136 
2008, from 2.1% to 0.6% in the level II hospital and from 1.5% to 1.0% in the level III hospital (Table 137 
2). In the level II unit, the prevalence of severe PPH decreased for both vaginal and caesarean 138 
deliveries. In the level III unit, on the other hand, the prevalence of severe PPH after vaginal deliveries 139 
fell significantly, but the prevalence after caesareans did not change. 140 
The global quality of care provided to women with severe PPH improved in both units between 2005 141 
and 2008, although the difference reached statistical significance only in the level III hospital (Table 142 
3). The proportion of cases for which management was considered optimal increased from 47% to 143 
73% in the level II unit and from 22% to 61% in the level III unit.  144 
In both units in 2005, the main deviations from recommended care once PPH was diagnosed were no 145 
or delayed examination of the uterine cavity (57% in the level II and 74% in the level III unit), the 146 
absence of instrumental examinations of vagina and cervix (76% and 59% of severe PPH cases, 147 
respectively), and no or delayed administration of second-line uterotonics when uterine atony persisted 148 
(71% and 86%). 149 
From 2005 to 2008, the proportion of deliveries with severe PPH that were managed consistently with 150 
the guidelines increased for all of the principal components, in both units. In particular, this 151 
improvement was statistically significant in both units for the components of care that were the most 152 
inappropriate in 2005. 153 
 154 
Discussion 155 
This study shows that routine clinical audits can easily be implemented in obstetrics settings and that 156 
their regular performance is associated with an improvement in PPH-related practices and with a 157 
significant reduction in the prevalence of severe PPH. 158 
 159 
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Several limitations must be noted. First although the initial audit meeting was part of a research 160 
programme, the routine use of the audit that followed was a local initiative in both units, and the 161 
external validity of the results may thus be questionable. Our findings nonetheless suggest that clinical 162 
audits are a simple and potentially effective tool for units willing to assess and improve the care they 163 
provide. 164 
The quality of care for PPH and the specific components of that care were analysed only in cases of 165 
severe PPH. A complete assessment of the audit impact would theoretically have required us to 166 
analyse practices in all cases of PPH, or in a representative sample of them, and not only in the most 167 
severe cases. These data, however, were not available. It is possible that the improvement in practices 168 
was actually greater than that observed in cases of severe PPH, since, by definition, the severe cases 169 
have worsened and are thus more likely to have received inappropriate care.  170 
The inherent limitations of our observational design prevent this study from proving that the regular 171 
audits caused the reduction in the prevalence of severe PPH, and other factors external to the audit 172 
may have contributed to this decrease. Obstetrics professionals in France have been focusing on the 173 
issue of PPH since the late 1990s, and global improvement in PPH-related practices might have been 174 
underway as part of this national context and could explain the decrease in the prevalence of severe 175 
PPH found in the 2 units of our study. We consider this hypothesis seems unlikely, however. Firstly, 176 
passive dissemination of recommendations for clinical practice has repeatedly been shown to be 177 
insufficient to improve practices (11)
.
 Secondly, the dramatic  reduction found here – with the 178 
prevalence of severe PPH after vaginal delivery divided by three -- seems unlikely to have happened 179 
in the absence of active intervention. Finally, a regional study in all maternity units of another French 180 
region showed no significant decrease in the rate of severe PPH during this time period (12).  181 
Another possible explanation of our results is that the proportion of women at risk for PPH decreased 182 
over time. However, neither the prevalence of PPH risk factors among parturient women nor the 183 
annual rate of all PPH decreased over this period. Indeed, an inverse trend was observed in the level 184 
III unit, where the rates of two important risk factors increased between 2005 and 2008: the number of 185 
instrumental deliveries and of women with previous caesareans. These changes may have contributed 186 
to the increase in the PPH rate. Under these circumstances, the reduction we observed in the 187 
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prevalence of severe PPH suggests a decline in the proportion of the PPH that worsened and became 188 
severe, probably due to better management of early PPH. The specific PPH-related practices used as 189 
criteria for determining quality of care improved concomitantly. Finally, the implementation of routine 190 
audits was associated with a significant reduction in severe PPH in two different maternity units 191 
providing different levels of care in different settings. All these elements suggest that the organisation 192 
of regular clinical audits is likely to have had a positive effect on the prevalence of severe PPH. 193 
 194 
Although there are reports of interventions aimed at improving the global quality of care delivered to 195 
mothers and children, or targeting other specific issues in obstetrics, previous studies of interventions 196 
to decrease the rate of severe PPH are scarce (13-14). Because those few tested the impact of complex 197 
or multifaceted interventions, they are not easily reproducible, and it is difficult to attribute the global 198 
effect to one component or another. Only one reported a significant reduction in the rate of severe 199 
PPH, obtained over a 3 year period in one centre (13). The present study provides a description of the 200 
routine use of one specific tool, the clinical audit, and our findings suggest it has a significant impact 201 
on the prevention of severe PPH through effective management of early bleeding. The precise 202 
description of the agenda of the audit meetings should make them easily reproducible in other units. In 203 
addition, the continuous monitoring of the prevalence of severe PPH and of the proportion of adequate 204 
care provides evidence that the audit's impact is sustained over time. 205 
 206 
A major strength of regular clinical audits is that they bring practitioners together frequently to discuss 207 
the management of severe cases and to define relevant improvement objectives appropriate to the local 208 
context and based on the audit's findings (15). Severe PPH is a very pertinent event for clinical audits, 209 
because of the availability of management guidelines and its obviously multidisciplinary nature, 210 
involving midwives, obstetricians, and anaesthetists. Such multidisciplinary meetings with a facilitator 211 
team applying strategies to encourage collaboration, both at the meeting and during care, are likely to 212 
increase the audit activity and to improve care.  213 
In our experience, the results that can be expected from a clinical audit meeting depend on several 214 
aspects of the audit process: institutional support, by treating participation in the meetings as actual 215 
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working time; respect for the facilitator team and their leadership skills; consideration for every 216 
participant‘s words; objective assessment of care provided with the help of a standardised form; 217 
analysis of the mechanisms that led to the severe event, focused not on individual mistakes, but on 218 
understanding individual and collective decision-making processes; and conclusions expressed in 219 
terms of improvement strategies. In addition, long-term repetition of the audit appears necessary for it 220 
to improve practices and health outcomes. In the level III unit, clear improvement appeared only 221 
during the third year of audits. This finding is consistent with the previous report from Rizvi et al of an 222 
intervention to decrease the rate of severe PPH (13). This is also likely to explain why no significant 223 
improvement was obtained in the Pithagore6 trial where only one audit meeting took place (10): a 224 
single meeting is probably insufficient for identifying suboptimal care and its reasons and is certainly 225 
insufficient for verifying its improvement. 226 
 227 
An interesting finding is the differential changes in the prevalence of severe PPH for vaginal and 228 
caesarean deliveries. Caesarean delivery is a recognized risk factor for severe PPH, and the baseline 229 
rates of severe PPH in 2005 were higher for caesarean than vaginal deliveries in both units. During the 230 
subsequent years and following the implementation of routine audits, the prevalence of severe PPH 231 
after vaginal delivery fell quite appreciably in both units. However, severe PPH at caesarean deliveries 232 
decreased only in the level II unit; it remained stable in the level III unit and these cases accounted for 233 
most of the severe PPH in 2008. The clinical guidelines for PPH management offer more detailed 234 
measures for dealing with bleeding after vaginal delivery; it is thus unsurprising that the audits might 235 
have had a greater impact on this type of PPH. The concomitant increase in the rate of all PPH after 236 
caesarean delivery found in the level III unit may indicate that the procedure itself was associated with 237 
a higher risk of bleeding in 2008 than in 2005. Although the mechanisms and management of PPH at 238 
caesarean deliveries include surgical issues that may be more difficult to standardise, the current 239 
continuous rise in caesarean rates indicates that guidelines focusing on the management of bleeding at 240 
caesarean delivery are needed.  241 
 242 
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The prevalence of severe PPH and the high proportion of inadequate management found at baseline in 243 
the two units of this study suggest that room for improvement exists. Because passive dissemination of 244 
guidelines does not change practices, specific interventions are required. One feasible tool is the 245 
regular clinical audit of severe PPH, and in this study, it was associated with a persistent reduction in 246 
the prevalence of severe PPH. 247 
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Table 1: Characteristics of pregnancy and delivery in parturient women, 2005 to 2008, in the 2 units 
 2005 2006 2007 2008  
Level II Unit n % n % n % n % P* 
All 1 538 100.0 1 469 100.0 1 552 100.0 1 899 100.0  
Previous caesarean 134 9,4    181 12,3   185 11,6   201   10,6 0.1 
Multiple pregnancy 43 2,9     22     1,5   42 2,6 38   2,0 0.3 
Placenta praevia  17 1,2     17     1,2     5 0,3 12     0,6 0.1 
Caesarean delivery  386 26,3   356 24,2 363 22,7 461   24,3 0.9 
Instrumental vaginal delivery 102 7.2   117   8.1 150  9.7 185     9.7 0.1 
Fetal macrosomia 109 7.2   109    7.3 110  6.9 140     7.2 0.9 
Postpartum haemorrhage 63 4.1    73 5   87  5.6   65     4.2 0.3 
          
Level III Unit n % n % n % n % P* 
All 2 962 100 3 113 100 3 058 100 3 213 100  
Previous caesarean 219    7,5 342 11,0  354   11.5 353  11,0 <0.01 
Multiple pregnancy  97     3,3 93     3,0  112     3,7   99   3,1 0.8 
Placenta praevia   31     1,1 38     1,2   33     1,1   35   1,1 0.6 
Caesarean delivery  636   21,8 691   22,2 682 22,3 706   22,0 0.8 
Instrumental vaginal delivery 216    7.3 234    7.5 299     9.8 343   10.5 <0.01 
Fetal macrosomia 210    6.9 221    6.9 215     6.8 218     6.6 0.6 
Postpartum haemorrhage 121   4.0 131   4,2 190     6.2 196     6.1 <0.01 
*Difference between 2005 and 2008 
 
  15 
Table 2 : Number and Rate (% of deliveries) of severe PPH*, 2005 to 2008, in the 2 units 
 2005 2006 2007 2008  
Level II Unit n % n % n % n % P** 
          
All Severe PPH 32 2.1     9     0.6    8  0.5 11     0.6 <0.01 
Severe PPH at vaginal delivery 21 1.8     6 0.5    3 0.3  8 0.6 <0.01 
Severe PPH at caesarean delivery 11 2.8     3 0.8  5 1.4  3 0.7 <0.01 
          
Level III Unit n % n % n % n % P** 
          
All Severe PPH  45   1.5  41    1.6 33     1.1  31     1.0 0.05 
Severe pph at vaginal delivery  27 1.2  25 1.0 16 0.7   9 0.4 <0.01 
Severe pph at caesarean delivery 18 2.8 16 2.3 17 2.5 22 3.1 0.8 
          
*severe PPH defined as a PPH associated with one or more of the following: blood transfusion, arterial embolisation, arterial ligation, other 
conservative uterine surgery, hysterectomy, transfer to an intensive care unit, peripartum haemoglobin delta of 4 g/dl or higher, or maternal 
death 
**Difference between 2005 and 2008  
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Table 3 : Characteristics of care provided for severe PPH, 2005 to 2008, in the 2 units 
 2005 2006 2007 2008  
Level II Unit n % n % n % n % P* 
 32 100 9 100 8 100 11 100  
▪ Global quality of care          
Optimal care 15 47 8 88 5 63 8 73 0.1 
Sub-optimal care  17 53 1 22 3 37 3 27  
Non-optimal care  0 0 0 0 0 0 0 0  
          
▪ Specific components of management          
All Severe PPH 32 100 9 100 8 100 11 100  
Administration of oxytocin 27 84 9 100 8 100 11 100 0.8 
Call for additional staff 28 88 8 89 8 100 10 91 0.9 
Severe PPH at vaginal delivery  21 100 6 100 3 100 8 100  
Pharmacological prophylaxis 10 48 5 83 2 67 7 88 0.1 
Examination of the uterine cavity  15 71 6 100 2 67 6 75 0.8 
within 15 minutes of PPH diagnosis 9 43 5 83 2 67 5 63 0.6 
Instrumental examination of vagina/cervix 5 24 6 100 3 100 7 88 <0.01 
Severe PPH due to uterine atony 21 100 7 100 7 100 6 100  
Intravenous administration of sulprostone 8 38 6 86 6 86 5 83 0.1 
within 30 min of PPH diagnosis 6 29 6 86 5 71 5 83 0.05 
          
Level III Unit n % n % n % n % P* 
 45 100 41 100 33 100 31 100  
▪ Global quality of care          
Optimal care 10 22 9 22 14 42 19 61 <0.01 
Sub-optimal care  24 53 27 66 18 55 11 35  
Non-optimal care  11 24 5 12 1 3 1 4  
          
▪ Specific components of management          
All Severe PPH 45 100 41 100 33 100 31 100  
Administration of oxytocin 43 96 36 88 32 97 31 100 0.9 
Call for additional staff 43 96 41 100 31 94 30 97 0.9 
Severe PPH at vaginal delivery  27 100 25 100 16 100 9 100  
Pharmacological prophylaxis  5  19 18  72 10 63 9 100 <0.01 
Examination of the uterine cavity  19  70 23  92 16 100 8  89 0.5 
within 15 minutes of PPH diagnosis  7  26 22  88 10 63 8  89 <0.01 
Instrumental examination of vagina/cervix 11  41 18 72 9 56 8  89 0.03 
Severe PPH due to uterine atony 35 100 29 100 14 100 19 100  
Intravenous administration of sulprostone 20  57 25  86 13 93 18  95 <0.01 
within 30 min of PPH diagnosis  5  14 16  55 7 50 18  95 <0.01 
          
* Difference between 2005 and 2008 
 
 
 
